J Korean Pediatr Cardiol Soc.  2007 Jun;11(2):106-111.

Clinical Study on Kawasaki Disease for Evidence-based Treatment

Affiliations
  • 1Department of Pediatrics, College of Medicine, Inje university, Busan Paik Hospital, Busan, Korea. msped@medimail.co.kr

Abstract

Evidence-based medicine is a medical movement combining professional experience with the best scientific research results. Treatment of Kawasaki disease in the acute phase is directed at reducing inflammation in the coronary artery wall and preventing coronary thrombosis, whereas long-term therapy in individuals who develop coronary aneurysms is aimed at preventing myocardial ischemia or infarction. I attempt to summarize the current state of knowledge of the medical management of patients with Kawasaki disease. The recommendations are evidence-based and derived from published data wherever possible.

Keyword

Kawasaki disease; Treatment; Evidence-based

MeSH Terms

Coronary Aneurysm
Coronary Thrombosis
Coronary Vessels
Evidence-Based Medicine
Humans
Infarction
Inflammation
Mucocutaneous Lymph Node Syndrome*
Myocardial Ischemia
Full Text Links
  • JKPCS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr